Malenka Robert C. sold MPLT

October 28, 2025 · Form 4 insider transaction

Malenka Robert C. sold 65,477 shares of MapLight Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
65,477
Price
$0.00
Total value
N/A
RoleDirector
SecuritySeries C Preferred Stock
Transaction codeC: Conversion of a derivative
Transaction dateOctober 28, 2025
Filing dateOctober 28, 2025
Shares owned after0
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The Series C Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.; The shares are held by the Robert C. Malenka Living Trust U/A DTD 08/21/2012, of which the Reporting Person is the sole trustee and has voting and dispositive power.

View the original Form 4 on SEC EDGAR